UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034160
Receipt number R000038945
Scientific Title Effect of Whey Protein Supplement on Plasma Glucose Levels in Japanese Patients with Inadequately Controlled Type 2 Diabetes
Date of disclosure of the study information 2020/12/31
Last modified on 2021/03/18 12:11:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Whey Protein Supplement on Plasma Glucose Levels in Japanese Patients with Inadequately Controlled Type 2 Diabetes

Acronym

Effect of Whey Protein Supplement on Plasma Glucose Levels

Scientific Title

Effect of Whey Protein Supplement on Plasma Glucose Levels in Japanese Patients with Inadequately Controlled Type 2 Diabetes

Scientific Title:Acronym

Effect of Whey Protein Supplement on Plasma Glucose Levels

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Inspect the effect of whey protein supplement on plasma glucose levels

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change of the HbA1c from baseline in the whey protein supplement performed after each 12 weeks

Key secondary outcomes

The change of the GA, GLP-1, GIP and PYY from baseline in the whey protein supplement performed after each 12 weeks
And the change of body composition by the Bioelectrical Impedance Analysis


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Trained nutritionists calculate ideal body weight and assess their daily diet.

Interventions/Control_2

Patients were instructed to add on 10% of total energy by whey protein supplement.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Outpatients.
2)HbA1c before clinical trial start is 7.0% or more and 8.0% less.
3)Over 20years old. Gender unquestioned.
4)Patients are being treated DPP-4 inhibitor for more than 6 months,and variation of HbA1c by <0.5% whithin 3 months before recruitment.
5)Written informed consent was obtained from all participants.

Key exclusion criteria

1)Type1 diabetic patients and Type2 diabetic patients who depend on insulin.
2)Patients have renal failure (estimated glomerular filtration rate <60mL/min/1.73m2).
3)Patients have severe liver disfunction.
4)Women who may be pregnant, may become pregnant and are breastfeeding.
5)Patients have malignancy or had treated to malignancy past five years.
6)Patients have admission to improve glycemic control within a past year before written consent.
7)Patients are using a drug with the influence for glucose metabolism (steroid, interferon, hormone drugs, antipsychotic drugs and antitubercular drugs).
8)Patients have allergy to protein or dairy product.
9)Patients who were judged to be ineligible by the investigator.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Tanaka

Organization

St. Marianna University School of Medicine

Division name

Division of Metabolism and endocrinology, Depertment of Internal Medicine

Zip code

2168511

Address

2-16-1 Sugao, Miyamae-ku, Kawaski, Kanagawa, Japan.

TEL

044-977-8111

Email

smu.tainai@gmail.com


Public contact

Name of contact person

1st name Yutaro
Middle name
Last name Yamamoto

Organization

St. Marianna University School of Medicine

Division name

Division of Metabolism and endocrinology, Depertment of Internal Medicine

Zip code

2168511

Address

2-16-1 Sugao, Miyamae-ku, Kawaski, Kanagawa, Japan.

TEL

044-977-8111

Homepage URL


Email

y3yamamoto@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Marianna University School of Medicine

Address

2-16-1 Sugao, Miyamae-ku, Kawaski, Kanagawa, Japan.

Tel

044-977-8111

Email

k-sienbu.mail@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖マリアンナ医科大学病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 31 Day


Related information

URL releasing protocol

none

Publication of results

Unpublished


Result

URL related to results and publications

none

Number of participants that the trial has enrolled

0

Results

Stopped as it falls under specific clinical research.

Results date posted

2021 Year 03 Month 18 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

none

Participant flow

none

Adverse events

none

Outcome measures

none

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 05 Month 07 Day

Date of IRB

2018 Year 05 Month 15 Day

Anticipated trial start date

2018 Year 10 Month 01 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 15 Day

Last modified on

2021 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038945


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name